Maccura Biotechnology Co Ltd
300463
Company Profile
Business description
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Contact
Number 8, 2nd Anhe Road
Hi-tech Zone
Chengdu611731
CHNT: +86 2881731888
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
3,362
Stocks News & Analysis
stocks
Signs of a turnaround for undervalued ASX share
Market likes the payoff from early efforts at reining in costs.
stocks
Australia has the highest dividend yields in the world, so why the endless chase for even higher yields?
Ashley Owen explores why investors' insatiable thirst for higher yields leads to unnecessarily complicating their portfolio.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,825.10 | 20.90 | 0.24% |
| CAC 40 | 8,178.54 | 14.43 | 0.18% |
| DAX 40 | 22,513.42 | 98.60 | -0.44% |
| Dow JONES (US) | 44,546.08 | 165.35 | -0.37% |
| FTSE 100 | 8,732.46 | 32.26 | -0.37% |
| HKSE | 22,620.33 | 805.96 | 3.69% |
| NASDAQ | 20,026.77 | 81.13 | 0.41% |
| Nikkei 225 | 39,149.43 | 312.04 | -0.79% |
| NZX 50 Index | 12,989.18 | 83.20 | 0.64% |
| S&P 500 | 6,114.63 | 0.44 | -0.01% |
| S&P/ASX 200 | 8,555.80 | 15.80 | 0.19% |
| SSE Composite Index | 3,346.72 | 14.24 | 0.43% |